+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis



Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis



Digestive and Liver Disease 50(8): 839-844



The knowledge of natural history of patients with portal hypertension (PH) not due to cirrhosis is less well known than that of cirrhotic patients. To describe the clinical presentation and the outcomes of 89 patients with non-cirrhotic PH (25 with non-cirrhotic portal hypertension, INCPH, and 64 with chronic portal vein thrombosis, PVT) in comparison with 77 patients with Child A cirrhosis. The patients were submitted to a standardized clinical, laboratory, ultrasonographic and endoscopic follow-up. Variceal progression, incidence of variceal bleeding, portal vein thrombosis, ascites and survival were recorded. At presentation, the prevalence of varices, variceal bleeding and ascites was similar in the 3 groups. During follow-up, the rate of progression to varices at risk of bleeding (p < 0.0001) and the incidence of first variceal bleeding (p = 0.02) were significantly higher in non-cirrhotic then in cirrhotic patients. A PVT developed in 32% of INCPH patients and in 18% of cirrhotics (p = 0.02). In the patients with non-cirrhotic PH variceal progression is more rapid and bleeding more frequent than in cirrhotics. Patients with INCPH are particularly prompt to develop PVT. This observational study suggests that the management of patients with non-cirrhotic PH should take into consideration the natural history of portal hypertension in these patients and cannot be simply derived by the observation of cirrhotic patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065344290

Download citation: RISBibTeXText

PMID: 29429910

DOI: 10.1016/j.dld.2018.01.132


Related references

Biliary lipid composition in patients with non-cirrhotic portal fibrosis--a comparison with compensated cirrhosis of the liver. Liver 7(1): 38-42, 1987

Biliary lipid composition in patients with non-cirrhotic portal fibrosis a comparison with compensated cirrhosis of the liver. Liver International 7(1): 38-42, 1987

TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Alimentary Pharmacology and Therapeutics 2019, 2019

The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. American Journal of Gastroenterology 99(10): 1959-1965, 2004

Natural history of portal hypertension in patients with cirrhosis. Clinics in Liver Disease 5(3): 645-663, 2001

Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis. Hepatology International 1(1): 275-280, 2007

Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension. Hepatology 2018, 2018

Predicting the presence of significant portal hypertension and varices in compensated cirrhotic patients. Hepatology 26(4 Part 2): 360A, 1997

Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis. Journal of Hepatology 39(3): 315-319, 2003

Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology 102(6): 2114-2119, 1992

Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension. Journal of Gastroenterology and Hepatology 6(1): 91-93, 1991

The effect of propranolol on variceal pressure is not different between patients with cirrhosis and patients with non-cirrhotic portal hypertension. Hepatology 28(4 Part 2): 658A, 1998

Cerebral function in unoperated patients with non-cirrhotic portal fibrosis: A comparison with compensated non-alcoholic cirrhotics. Journal of Gastroenterology and Hepatology 2(1): 9-12, 1987

Presepsin (Soluble CD14 Subtype) Levels in Cirrhotic Patients with Compensated or Decompensated Liver Disease with or without Portal Hypertension Related Bleeding. Journal of Hepatology 64(2): S659-S660, 2016

Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144(1): 102-111.E1, 2013